334 related articles for article (PubMed ID: 19033562)
1. Obesity, mammography use and accuracy, and advanced breast cancer risk.
Kerlikowske K; Walker R; Miglioretti DL; Desai A; Ballard-Barbash R; Buist DS
J Natl Cancer Inst; 2008 Dec; 100(23):1724-33. PubMed ID: 19033562
[TBL] [Abstract][Full Text] [Related]
2. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
[TBL] [Abstract][Full Text] [Related]
3. The association between obesity and screening mammography accuracy.
Elmore JG; Carney PA; Abraham LA; Barlow WE; Egger JR; Fosse JS; Cutter GR; Hendrick RE; D'Orsi CJ; Paliwal P; Taplin SH
Arch Intern Med; 2004 May; 164(10):1140-7. PubMed ID: 15159273
[TBL] [Abstract][Full Text] [Related]
4. Overweight, obesity, and breast cancer screening: results from the 2012 Swiss Health Survey.
Eichholzer M; Richard A; Rohrmann S; Schmid S; Güth U
Eur J Cancer Prev; 2016 Mar; 25(2):130-6. PubMed ID: 25793921
[TBL] [Abstract][Full Text] [Related]
5. 'Weighing in' on screening mammography.
Berz D; Sikov W; Colvin G; Weitzen S
Breast Cancer Res Treat; 2009 Apr; 114(3):569-74. PubMed ID: 18491226
[TBL] [Abstract][Full Text] [Related]
6. Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype.
Shieh Y; Scott CG; Jensen MR; Norman AD; Bertrand KA; Pankratz VS; Brandt KR; Visscher DW; Shepherd JA; Tamimi RM; Vachon CM; Kerlikowske K
Breast Cancer Res; 2019 Apr; 21(1):48. PubMed ID: 30944014
[TBL] [Abstract][Full Text] [Related]
7. Obesity and breast cancer screening: Cross-sectional survey results from the behavioral risk factor surveillance system.
Miles RC; Lehman CD; Mercaldo SF; Tamimi RM; Dontchos BN; Narayan AK
Cancer; 2019 Dec; 125(23):4158-4163. PubMed ID: 31393609
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
Kerlikowske K; Zhu W; Hubbard RA; Geller B; Dittus K; Braithwaite D; Wernli KJ; Miglioretti DL; O'Meara ES;
JAMA Intern Med; 2013 May; 173(9):807-16. PubMed ID: 23552817
[TBL] [Abstract][Full Text] [Related]
9. Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI.
Dittus K; Geller B; Weaver DL; Kerlikowske K; Zhu W; Hubbard R; Braithwaite D; O'Meara ES; Miglioretti DL;
J Gen Intern Med; 2013 Nov; 28(11):1454-62. PubMed ID: 23760741
[TBL] [Abstract][Full Text] [Related]
10. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
Kerlikowske K; Miglioretti DL; Buist DS; Walker R; Carney PA;
J Natl Cancer Inst; 2007 Sep; 99(17):1335-9. PubMed ID: 17698950
[TBL] [Abstract][Full Text] [Related]
11. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
12. Association of the Interaction Between Mammographic Breast Density, Body Mass Index, and Menopausal Status With Breast Cancer Risk Among Korean Women.
Tran TXM; Moon SG; Kim S; Park B
JAMA Netw Open; 2021 Dec; 4(12):e2139161. PubMed ID: 34940866
[TBL] [Abstract][Full Text] [Related]
13. Body mass index and participation in organized mammographic screening: a prospective cohort study.
Hellmann SS; Njor SH; Lynge E; von Euler-Chelpin M; Olsen A; Tjønneland A; Vejborg I; Andersen ZJ
BMC Cancer; 2015 Apr; 15():294. PubMed ID: 25880028
[TBL] [Abstract][Full Text] [Related]
14. The association between body mass index and immunohistochemical subtypes in breast cancer.
Sahin S; Erdem GU; Karatas F; Aytekin A; Sever AR; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():227-236. PubMed ID: 27756509
[TBL] [Abstract][Full Text] [Related]
15. Prospective breast cancer risk prediction model for women undergoing screening mammography.
Barlow WE; White E; Ballard-Barbash R; Vacek PM; Titus-Ernstoff L; Carney PA; Tice JA; Buist DS; Geller BM; Rosenberg R; Yankaskas BC; Kerlikowske K
J Natl Cancer Inst; 2006 Sep; 98(17):1204-14. PubMed ID: 16954473
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density.
Hou N; Hong S; Wang W; Olopade OI; Dignam JJ; Huo D
J Natl Cancer Inst; 2013 Sep; 105(18):1365-72. PubMed ID: 24003037
[TBL] [Abstract][Full Text] [Related]
17. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?
Braithwaite D; Zhu W; Hubbard RA; O'Meara ES; Miglioretti DL; Geller B; Dittus K; Moore D; Wernli KJ; Mandelblatt J; Kerlikowske K;
J Natl Cancer Inst; 2013 Mar; 105(5):334-41. PubMed ID: 23385442
[TBL] [Abstract][Full Text] [Related]
18. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
[TBL] [Abstract][Full Text] [Related]
19. Postmenopausal overweight and breast cancer risk; results from the KARMA cohort.
Klintman M; Rosendahl AH; Randeris B; Eriksson M; Czene K; Hall P; Borgquist S
Breast Cancer Res Treat; 2022 Nov; 196(1):185-196. PubMed ID: 36040641
[TBL] [Abstract][Full Text] [Related]
20. Breast Cancer Characteristics Associated With Digital Versus Film-Screen Mammography for Screen-Detected and Interval Cancers.
Henderson LM; Miglioretti DL; Kerlikowske K; Wernli KJ; Sprague BL; Lehman CD
AJR Am J Roentgenol; 2015 Sep; 205(3):676-84. PubMed ID: 26295657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
